针灸治疗慢性阻塞性肺疾病：一项系统评价方案

Acupuncture for the treatment of chronic obstructive pulmonary disease: a protocol of a systematic review.

作者信息

Choi Tae-Young, Jun Ji Hee, Choi Jun-Young, Kim Jong-In, Lee Myeong Soo, Ernst Edzard

机构信息

Medical Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.

出版信息

BMJ Open. 2014 Apr 28;4(4):e004590. doi: 10.1136/bmjopen-2013-004590.

DOI:10.1136/bmjopen-2013-004590

PMID:24776710

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4010841/

Abstract

INTRODUCTION

This review aims to evaluate the efficacy of acupuncture in the treatment of chronic obstructive pulmonary disease (COPD).

METHODS AND ANALYSIS

14 databases will be searched from their inception. These include PubMed, AMED, EMBASE, the Cochrane Library, seven Korean medical databases (Korean Studies Information Service System, DBPIA, Oriental Medicine Advanced Searching Integrated System, Research Information Service System, KoreaMed, The Town Society of Science Technology and the Korean National Assembly Library), three Chinese Databases (China National Knowledge Infrastructure Database (CNKI), the Chongqing VIP Chinese Science and Technology Periodical Database (VIP), and the Wanfang Database). Only randomised clinical trials (RCTs) using acupuncture for COPD will be considered. The selection of the studies, data abstraction and validation will be performed independently by two researchers. Methodological quality will be assessed with the Cochrane risk of bias.

DISSEMINATION

The systematic review will be published in a peer-reviewed journal. The review will also be disseminated electronically and in print. Updates of the review will be conducted to inform and guide the healthcare practice and policy.

TRIAL REGISTRATION NUMBER

PROSPERO 2013: CRD42013004824.

摘要

引言

本综述旨在评估针灸治疗慢性阻塞性肺疾病（COPD）的疗效。

方法与分析

将检索14个自建库以来的数据库。这些数据库包括PubMed、AMED、EMBASE、Cochrane图书馆、七个韩国医学数据库（韩国研究信息服务系统、DBPIA、东方医学高级检索集成系统、研究信息服务系统、KoreaMed、科学技术镇社会和韩国国会图书馆）、三个中国数据库（中国知网数据库（CNKI）、重庆维普中文科技期刊数据库（VIP）和万方数据库）。仅纳入使用针灸治疗COPD的随机临床试验（RCT）。研究的筛选、数据提取和验证将由两名研究人员独立进行。方法学质量将采用Cochrane偏倚风险评估。